Literature DB >> 7675318

Chronic imipramine, L-sulpiride and mianserin decrease corticotropin releasing factor levels in the rat brain.

P Fadda1, L Pani, A Porcella, W Fratta.   

Abstract

Among clinically effective antidepressant drugs, the action mechanism of mianserin has recently been related to variations in corticotropin releasing factor (CRF) levels in the rat locus coeruleus. We describe a specific effect on CRF levels after chronic treatment with different antidepressants: mianserin (10 mg/kg), imipramine (20 mg/kg), both for 21 days, or L-sulpiride (1 mg/kg) for 15 days. While all antidepressants used greatly decreased CRF concentrations in the hypothalamus, only mianserin decreased CRF concentrations by 40% in extrahypothalamic sites. Acute treatments failed to modify CRF levels. Chronic treatment with mianserin did not affect CRF density either in the hypothalamus or the extrahypothalamic areas. This new finding may add another facet to the therapeutic action of certain antidepressants and in particular to the atypical profile of mianserin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675318     DOI: 10.1016/0304-3940(95)11612-z

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  Behavioral animal models of depression.

Authors:  Hua-Cheng Yan; Xiong Cao; Manas Das; Xin-Hong Zhu; Tian-Ming Gao
Journal:  Neurosci Bull       Date:  2010-08       Impact factor: 5.203

2.  Saliva estriol levels in women with and without prenatal antidepressant treatment.

Authors:  Rita Suri; Gerhard Hellemann; Lee Cohen; Ana Aquino; Lori Altshuler
Journal:  Biol Psychiatry       Date:  2008-05-21       Impact factor: 13.382

3.  Inhibition of the CRF1 receptor influences the activity of antidepressant drugs in the forced swim test in rats.

Authors:  Andrzej Wróbel; Anna Serefko; Aleksandra Szopa; Karol Rojek; Ewa Poleszak; Krystyna Skalicka-Woźniak; Jarosław Dudka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-20       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.